(Merz Pharma GmbH
& Co. KGaA
), a member of Merz Pharma
, is an international healthcare company specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Based in Germany
, Merz is a leader in the field of Alzheimer's disease
research and developed memantine
as the first drug for the treatment of moderate to severe Alzheimer's disease. Other franchises covered by Merz are hepatology / metabolic diseases and dermatology.